CME/CE: Stroke Rounds: Too Much Time from Thrombolysis to Brain Bleed Dx
Publication Date:
Sun, 11/01/2015
By: Alere Staff
SPONSORED BY
MedPage Today
American Heart Association
ACTIVE DATE
October 27, 2015 – October 27, 2017
CREDIT
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
DESCRIPTION
Treatment of symptomatic intracerebral hemorrhage (sICH) did not significantly reduce the likelihood of in-hospital mortality or hematoma expansion, according to a multicenter, retrospective study. The authors point out that shortening the time to diagnosis and treatment may be a key variable in improving outcomes of patients with sICH.
LINK
For Healthcare Professionals
- Getting Started with Home INR Monitoring
- Continuing Education
- Patient Education
-
Recent News
- Alere Initiates Voluntary Withdrawal for the Alere INRatio® PT/INR Monitor System
- Alere Initiates Voluntary Urgent Medical Device Correction for the Alere INRatio® PT/INR Monitor System
- Alere Initiates Voluntary Urgent Product Recall of the Alere INRatio®2 PT/INR Professional Test Strip
- Roche Initiates Voluntary Urgent Product Recall of CoaguChek® XS, CoaguChek XS Plus, and CoaguChek XS Pro Meters
- Effect of PST on Warfarin Management and Major Clinical Outcomes
- New Agents Get Second Opinion for First Line Use
- Tools for Your Anticoagulation Patients
- Alere Webinars